CDKN2A and neoplasm: For instance, the dysregulation of the CDKN2A-CDK4/6 axis in LC4 cells makes the 2D model particularly suited for preclinical testing of CDK4/6 inhibitors, allowing focused analysis of tumor cell behavior in a controlled environment free from stromal influences [10].